Nexalin Technology Stock Scheduled to Reverse Split on Monday, August 31st (NASDAQ:NXL)

Posted by Geri Gentry on Aug 27th, 2026

Nexalin Technology, Inc. (NASDAQ:NXL – Free Report)’s stock is scheduled to reverse split on the morning of Monday, August 31st. The 1-30 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, August 30th.

Nexalin Technology Stock Performance

Shares of NASDAQ NXL traded down $0.04 during mid-day trading on Thursday, reaching $0.25. The company’s stock had a trading volume of 1,202,822 shares, compared to its average volume of 122,112. The stock has a fifty day moving average of $0.37 and a two-hundred day moving average of $0.41. Nexalin Technology has a 52 week low of $0.22 and a 52 week high of $2.00.

Nexalin Technology (NASDAQ:NXL – Get Free Report) last released its earnings results on Wednesday, August 12th. The company reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.01). The company had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.09 million. Nexalin Technology had a negative return on equity of 278.24% and a negative net margin of 4,141.94%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Nexalin Technology from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 18th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Nexalin Technology currently has an average rating of “Sell”.

View Our Latest Stock Report on Nexalin Technology

Institutional Trading of Nexalin Technology

Institutional investors have recently bought and sold shares of the stock. Susquehanna International Group LLP acquired a new stake in shares of Nexalin Technology in the third quarter worth $57,000. Renaissance Technologies LLC increased its position in shares of Nexalin Technology by 119.2% in the fourth quarter. Renaissance Technologies LLC now owns 122,100 shares of the company’s stock valued at $68,000 after buying an additional 66,400 shares in the last quarter. PEAK6 LLC purchased a new stake in Nexalin Technology in the 2nd quarter worth $79,000. Geode Capital Management LLC raised its position in shares of Nexalin Technology by 23.4% during the 4th quarter. Geode Capital Management LLC now owns 150,274 shares of the company’s stock worth $84,000 after purchasing an additional 28,454 shares during the last quarter. Finally, AWM Investment Company Inc. purchased a new stake in Nexalin Technology during the 2nd quarter worth approximately $18,135,000. 0.65% of the stock is currently owned by institutional investors and hedge funds.

Nexalin Technology Company Profile

(Get Free Report)

Nexalin Technology, Inc is a U.S.-based medical device company specializing in noninvasive neuromodulation therapies for mental health conditions. The company develops and markets the Nexalin® medical device platform, which delivers proprietary alternating current waveforms to targeted areas of the brain through forehead-mounted electrodes. Its technology is designed to modulate neural activity without pharmaceuticals, positioning the company within the growing field of digital therapeutics and neurostimulation.

The Nexalin device has received U.S.